Matches in SemOpenAlex for { <https://semopenalex.org/work/W1989941856> ?p ?o ?g. }
Showing items 1 to 82 of
82
with 100 items per page.
- W1989941856 endingPage "314" @default.
- W1989941856 startingPage "310" @default.
- W1989941856 abstract "Introduction. This study was aimed at evaluating the safety and efficacy of brinzolamide 1% suspension (Azopt? 1%) and travoprost 0.004% (Travatan?) combined therapy in patients with open-angle glaucoma or ocular hypertension who are in need of additional intraocular pressure lowering. Material and methods. This is a prospective, three-month, open-label, clinical study. Forty patients (80 eyes) with primary open-angle glaucoma or ocular hypertension on Travatan? treatment and with unsatis-factory results in lowering intraocular pressure were included in the study. The qualifying intraocular pressure on previous treatment with Travatan? (at least 6 weeks) was 22-36 mmHg in at least one eye at 8 a.m. intraocular pressure measurements at three eligibility visits. The patients received brinzolamide 1% twice a day in addition to travoprost 0.004% given once a day in the evening for 3 months. The follow-up examinations assessing the safety and efficacy of combined therapy of brinzolamide 1% and travoprost 0.004% were performed after 1 and 3 months. Results. Adjunctive therapy with brinzolamide resulted in statistically significant reductions in intraocular pressure from the travoprost baseline at all visits. Treatment with brinzolamide/travoprost caused statistically significant sustained reduction in intraocular pressure with the reduction of 17.39% (p<0.001) after 4 weeks and 20.08% (p<0.001) after 12 weeks. The intraocular pressure change from the baseline ranged from -3.9 mmHg after 4 weeks to -4.48 mmHg after 12 weeks. The most frequently related adverse effect was abnormal taste and blurred vision. Conclusion. Brinzolamide 1% (b.i.d.) used adjunctively with travoprost 0.004% (q.d.) lowers intraocular pressure significantly compared to travoprost alone. Both drugs were well tolerated and safe in the studied patients." @default.
- W1989941856 created "2016-06-24" @default.
- W1989941856 creator A5012883979 @default.
- W1989941856 creator A5052102918 @default.
- W1989941856 creator A5058371658 @default.
- W1989941856 creator A5063528809 @default.
- W1989941856 creator A5074280489 @default.
- W1989941856 date "2011-01-01" @default.
- W1989941856 modified "2023-10-16" @default.
- W1989941856 title "Adjunctive therapy with brinzolamide in patients on travoprost treatment" @default.
- W1989941856 cites W1966093962 @default.
- W1989941856 cites W1976253654 @default.
- W1989941856 cites W1981684730 @default.
- W1989941856 cites W2009358142 @default.
- W1989941856 cites W2036261669 @default.
- W1989941856 cites W2039015545 @default.
- W1989941856 cites W2040322156 @default.
- W1989941856 cites W2083891344 @default.
- W1989941856 cites W2110897487 @default.
- W1989941856 cites W2118638775 @default.
- W1989941856 cites W2119456426 @default.
- W1989941856 cites W2135699266 @default.
- W1989941856 cites W2141949039 @default.
- W1989941856 doi "https://doi.org/10.2298/mpns1106310b" @default.
- W1989941856 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/21789924" @default.
- W1989941856 hasPublicationYear "2011" @default.
- W1989941856 type Work @default.
- W1989941856 sameAs 1989941856 @default.
- W1989941856 citedByCount "0" @default.
- W1989941856 crossrefType "journal-article" @default.
- W1989941856 hasAuthorship W1989941856A5012883979 @default.
- W1989941856 hasAuthorship W1989941856A5052102918 @default.
- W1989941856 hasAuthorship W1989941856A5058371658 @default.
- W1989941856 hasAuthorship W1989941856A5063528809 @default.
- W1989941856 hasAuthorship W1989941856A5074280489 @default.
- W1989941856 hasBestOaLocation W19899418561 @default.
- W1989941856 hasConcept C118487528 @default.
- W1989941856 hasConcept C121332964 @default.
- W1989941856 hasConcept C126322002 @default.
- W1989941856 hasConcept C1276947 @default.
- W1989941856 hasConcept C197934379 @default.
- W1989941856 hasConcept C2776476923 @default.
- W1989941856 hasConcept C2776521421 @default.
- W1989941856 hasConcept C2778527774 @default.
- W1989941856 hasConcept C2779159986 @default.
- W1989941856 hasConcept C2780276452 @default.
- W1989941856 hasConcept C2781092963 @default.
- W1989941856 hasConcept C71924100 @default.
- W1989941856 hasConceptScore W1989941856C118487528 @default.
- W1989941856 hasConceptScore W1989941856C121332964 @default.
- W1989941856 hasConceptScore W1989941856C126322002 @default.
- W1989941856 hasConceptScore W1989941856C1276947 @default.
- W1989941856 hasConceptScore W1989941856C197934379 @default.
- W1989941856 hasConceptScore W1989941856C2776476923 @default.
- W1989941856 hasConceptScore W1989941856C2776521421 @default.
- W1989941856 hasConceptScore W1989941856C2778527774 @default.
- W1989941856 hasConceptScore W1989941856C2779159986 @default.
- W1989941856 hasConceptScore W1989941856C2780276452 @default.
- W1989941856 hasConceptScore W1989941856C2781092963 @default.
- W1989941856 hasConceptScore W1989941856C71924100 @default.
- W1989941856 hasIssue "5-6" @default.
- W1989941856 hasLocation W19899418561 @default.
- W1989941856 hasLocation W19899418562 @default.
- W1989941856 hasOpenAccess W1989941856 @default.
- W1989941856 hasPrimaryLocation W19899418561 @default.
- W1989941856 hasRelatedWork W1569303648 @default.
- W1989941856 hasRelatedWork W1975088893 @default.
- W1989941856 hasRelatedWork W1987931137 @default.
- W1989941856 hasRelatedWork W2027788223 @default.
- W1989941856 hasRelatedWork W2046688990 @default.
- W1989941856 hasRelatedWork W2128476364 @default.
- W1989941856 hasRelatedWork W2377183459 @default.
- W1989941856 hasRelatedWork W2403480076 @default.
- W1989941856 hasRelatedWork W2590468643 @default.
- W1989941856 hasRelatedWork W2769339337 @default.
- W1989941856 hasVolume "64" @default.
- W1989941856 isParatext "false" @default.
- W1989941856 isRetracted "false" @default.
- W1989941856 magId "1989941856" @default.
- W1989941856 workType "article" @default.